Literature DB >> 8138595

Growth regulation of human glioblastoma T98G cells by insulin-like growth factor-1 and its receptor.

D Ambrose1, M Resnicoff, D Coppola, C Sell, M Miura, S Jameson, R Baserga, R Rubin.   

Abstract

The interaction of insulin-like growth factors (IGFs) with the IGF-1 receptor is an important step in the control of cell proliferation and development. In particular, IGF-1 and IGF-2 are key regulators of central nervous system development, and may modulate the growth of glial tumors. We have investigated the growth factor regulation of the human glioblastoma cell line T98G. These cells growth arrested in serum-free medium at 34 degrees C, despite their secretion of substantial amounts of bioactive IGF-1. To be stimulated to divide, growth-arrested cells required the addition of platelet-derived growth factor (PDGF) or its equivalent, 1% serum. Cell proliferation in serum-free medium could also be obtained by shifting the cells to a temperature of 39.6 degrees C. Treatment of growth-arrested cells with PDGF or temperature shift was accompanied by a transient increase in the expression of the mRNA for the IGF-1 receptor. Transfection with a plasmid constitutively expressing the full cDNA for the human IGF-1 receptor allowed autonomous growth in serum-free medium at 34 degrees C. By contrast, growth induction by growth factors or temperature shift was abrogated by transfection of the cells with a plasmid expressing a 300 bp segment of mRNA antisense to the IGF-1 receptor mRNA. Cloning in soft agar was also inhibited by expression of antisense IGF-1 receptor mRNA. These results demonstrate that the IGF-1 receptor is strictly required for the growth of T98G glioblastoma cells. Moreover, the autocrine interaction of IGF-1 with its receptor regulates both autonomous and anchorage-independent growth of these cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8138595     DOI: 10.1002/jcp.1041590113

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  8 in total

Review 1.  Growth factors in gliomas: antisense and dominant negative mutant strategies.

Authors:  J W Campbell; I F Pollack
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

2.  Insulin-like growth factor receptor cooperates with integrin alpha v beta 5 to promote tumor cell dissemination in vivo.

Authors:  P C Brooks; R L Klemke; S Schon; J M Lewis; M A Schwartz; D A Cheresh
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

3.  Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1.

Authors:  H Werner; C T Roberts; F J Rauscher; D LeRoith
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

4.  Treatment of murine breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor decreases the level of plasminogen activator transcripts, inhibits cell growth in vitro, and reduces tumorigenesis in vivo.

Authors:  C L Chernicky; H Tan; L Yi; J R Loret de Mola; J Ilan
Journal:  Mol Pathol       Date:  2002-04

5.  Antiproliferative and apoptotic effect of ascorbyl stearate in human glioblastoma multiforme cells: modulation of insulin-like growth factor-I receptor (IGF-IR) expression.

Authors:  K A Naidu; J L Tang; K A Naidu; L D Prockop; S V Nicosia; D Coppola
Journal:  J Neurooncol       Date:  2001-08       Impact factor: 4.130

6.  Antiproliferative and proapoptotic effect of ascorbyl stearate in human pancreatic cancer cells: association with decreased expression of insulin-like growth factor 1 receptor.

Authors:  K Akhilender Naidu; Richard C Karl; Kamatham A Naidu; Domenico Coppola
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

7.  Dual targeting of IGF-1R and PDGFR inhibits proliferation in high-grade gliomas cells and induces radiosensitivity in JNK-1 expressing cells.

Authors:  Mia Carapancea; Daria Cosaceanu; Raluca Budiu; Anna Kwiecinska; Ligia Tataranu; Vasile Ciubotaru; Oana Alexandru; Monica Banita; Catalina Pisoschi; Magnus L Bäcklund; Rolf Lewensohn; Anica Dricu
Journal:  J Neurooncol       Date:  2007-06-14       Impact factor: 4.130

8.  In situ visualization of intratumor growth factor signaling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms.

Authors:  J W Mandell; I M Hussaini; M Zecevic; M J Weber; S R VandenBerg
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.